Collection of Blood and Urine Samples in Patients Receiving Radiation Therapy for Glioblastoma Multiforme
for
Glioblastoma Multiforme
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT00083512
Recruiting
Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas
for
Sarcoma, Sarcoma, Ewing, Desmoplastic Small Round Cell Tumor,
Location: Boston MA
Sponsor: David S Shulman, MD
Sex: All
Age: 12 - 49
Code: NCT06709495
Phase1, Phase2, Recruiting
Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy
for
Duodenal Neoplasm, Pancreatic Neoplasm
Location: Minneapolis MN
Sponsor: Masonic Cancer Center, University of Minnesota
Sex: All
Age: 18+
Code: NCT06411795
Phase2, Recruiting
MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma
for
IDH1 wt Allele, Recurrent Anaplastic Astrocytoma,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT03896568
Phase1, Recruiting
Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma
for
Peripheral T Cell Lymphoma, Relapsed Peripheral T-Cell Lymphoma,
Location: Rochester MN, Scottsdale AZ
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT06508463
Phase1, Recruiting
Interested in new pediatric cancer trials?
Get alerts for new trials in your area by subscribing now
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
for
Hematopoietic and Lymphoid Cell Neoplasm, Immunocompromised
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 0+
Code: NCT03425526
Phase1, Recruiting
International Rare Histiocytic Disorders Registry (IRHDR)
for
Rare Histiocytic Disorders (RHDs),
Location: Boston MA, New York NY, Toronto, Pittsburgh PA,
Sponsor: The Hospital for Sick Children
Sex: All
Age: 0+
Code: NCT02285582
Recruiting
Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas
for
Bone Sarcoma, Osteosarcoma, Chondrosarcoma, Ewing's Sarcoma,
Location: Uniondale NY, Harrison NY, New York NY, Middletown NJ,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 4+
Code: NCT03442465
Recruiting
Arginine and Whole Brain Radiation Therapy for the Treatment of Patients With Brain Metastases
for
Metastatic Malignant Neoplasm in the Brain,
Location: Atlanta GA
Sponsor: Emory University
Sex: All
Age: 18+
Code: NCT06328686
Early_phase1, Recruiting
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
for
Urinary Bladder Neoplasms, Neoplasm Metastasis,
Location: Boston MA, The Bronx NY, New York NY, Burlington VT,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT05614739
Phase1, Recruiting
Bendamustine With or Without Cyclophosphamide in Preventing GVHD in Patients Undergoing Stem Cell Transplant
for
Hematopoietic and Lymphoid System Neoplasm
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18 - 70
Code: NCT04022239
Phase1, Phase2, Recruiting
Registry to Collect Health Information About Desmoplastic Small Round Cell Tumor
for
Desmoplastic Small Round Cell Tumor
Location: New York NY
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 0+
Code: NCT04690374
Recruiting
Telemedicine for Improvement of Care for Older Adults With Cancer in the Underserved Community, The GAIN-S Trial
for
Hematopoietic and Lymphoid System Neoplasm,
Location: Upland CA, Lancaster CA, Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 65+
Code: NCT06022965
Recruiting
A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
for
B-Cell Non-Hodgkin Lymphoma,
Location: Rochester MN, Scottsdale AZ
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT03017820
Phase1, Recruiting
An Optimal Dose Finding Study of N-Acetylcysteine in Patients With Myeloproliferative Neoplasms